disease 3,759 words KG: ent-dise-7446954b
Contents

Frontotemporal Dementia

Disease Info
Typical OnsetTypically 45-65 years, though ranges from 20-80 years
Behavioral Variant FTD (bvFTD)Characterized by disinhibition, apathy, loss of empathy, compulsivity, and dietary changes
Logopenic Variant PPA (lvPPA)Word-finding pauses and memory lapses
Age-specific10-20 per 100,000 in individuals aged 45-64 years
Gender distributionSlight male predominance (1.5:1) in bvFTD
SurvivalMedian survival 6-11 years from symptom onset
Type ANeuronal intranuclear inclusions (NII) and neuronal cytoplasmic inclusions (NCI); associated with **GRN** mutations
Type BDiffuse NCI without NII; associated with **C9orf72** expansions
Type CNCI predominant; typical of semantic variant PPA
VCP-associatedInclusion body myopathy with Paget disease of bone (IBMPFD) and FTD; **VCP** mutations cause TDP-43 pathology
Pick's Disease3R tau filaments, Pick bodies, focal frontal/temporal atrophy
Argyrophilic Grain Disease (AGD)Argyrophilic grain disease, 4R tau, mild cognitive impairment
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (80)

Pharmacological Enhancement of APOE4 Glycosylation
Score: 0.62
Low Complexity Domain Cross-Linking Inhibition
Score: 0.62
Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar
Score: 0.61
Netrin-1 Gradient Restoration
Score: 0.59
VCP-Mediated Autophagy Enhancement
Score: 0.59
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
Synaptic Vesicle Tau Capture Inhibition
Score: 0.58
Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54
HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor
Score: 0.54
Lysosomal Membrane Repair Enhancement
Score: 0.54
Cryptic Exon Silencing Restoration
Score: 0.53
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.53
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.47
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.43
Microbial Inflammasome Priming Prevention
Score: 0.65
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
Lysosomal Positioning Dynamics Modulation
Score: 0.69
Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.55
← Prevpg 4/4

Related Analyses (21)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived

Related Experiments (22)

Tau ASO Therapy
validation · proposed · Score: 0.40
Epigenetic Clocks in Neurodegeneration — Causal Drivers or P
validation · completed · Score: 0.40
Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40
FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40
Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.